Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine.

Semin Arthritis Rheum · 2023 · PMC9911151 · PMID 36796211

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The percentage achieving a normal humoral response for anti-RBD was numerically greater among those holding DMARDs (71%) versus continuing DMARDs (50%), but this did not reach statistical significance ( Table 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.